QIAGEN (QGEN)
(Delayed Data from NYSE)
$42.18 USD
+1.07 (2.60%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $42.20 +0.02 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Price, Consensus and EPS Surprise
QGEN 42.18 +1.07(2.60%)
Will QGEN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for QGEN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for QGEN
QIAGEN (QGEN) Expands in NGS and FIGG With New Partnership
Hologic (HOLX) Moves Up 2% in a Week: Time to Consider Buying?
QGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
QIAGEN (QGEN) Backs New AAP Guidelines Supporting QFT-Plus Test
QIAGEN's (QGEN) New QCI Interpret Release Enhances AI Functions
QIAGEN (QGEN) Debuts dPCR Microbial DNA Detection Assays
Other News for QGEN
QIAGEN to enhance the identification of human remains of Indigenous people and African Americans
QIAGEN N.V. to release results for Q2 2024 and hold webcast
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children
What You Missed On Wall Street This Morning
Dynatrace initiated, U.S. Bancorp downgraded: Wall Street's top analyst calls